日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Struct2SL: Synthetic lethality prediction based on AlphaFold2 structure information and Multilayer Perceptron

Struct2SL:基于AlphaFold2结构信息和多层感知器的合成致死性预测

Huang, Yurui; Yuan, Ruzhe; Li, Yaxuan; Xing, Zheming; Li, Junyi

New insights into the role of macrophages in cancer immunotherapy

巨噬细胞在癌症免疫治疗中的作用的新见解

Zhou, Li; Zhao, Tiantian; Zhang, Ruzhe; Chen, Chen; Li, Jiwei

Smart Targeted Delivery Systems for Enhancing Antitumor Therapy of Active Ingredients in Traditional Chinese Medicine

用于增强中药活性成分抗肿瘤疗效的智能靶向递送系统

Kang, Chenglong; Wang, Jianwen; Li, Ruotong; Gong, Jianing; Wang, Kuanrong; Wang, Yuxin; Wang, Zhenghua; He, Ruzhe; Li, Fengyun

PDL1-Based Nomogram May Be of Potential Clinical Utility for Predicting Survival Outcome in Stage III Breast Cancer.

基于 PDL1 的列线图可能具有预测 III 期乳腺癌生存结果的潜在临床应用价值

Zhang Xi, Li Ruzhe, Wang Guonian

Differentiation-inducing factor 1 activates cofilin through pyridoxal phosphatase and AMP-activated protein kinase, resulting in mitochondrial fission

分化诱导因子 1 通过吡哆醛磷酸酶和 AMP 活化蛋白激酶激活肌动蛋白丝切蛋白,导致线粒体裂变

Takeru Inoue, Koichi Miura, Ruzhe Han, Fumi Seto-Tetsuo, Masaki Arioka, Kazunobu Igawa, Katsuhiko Tomooka, Toshiyuki Sasaguri

The combination of fibrinogen concentrations and the platelet-to-lymphocyte ratio predicts survival in patients with advanced lung adenocarcinoma treated with EGFR-TKIs

纤维蛋白原浓度和血小板与淋巴细胞比值的组合可预测接受 EGFR-TKI 治疗的晚期肺腺癌患者的生存期

He, Qiong; Li, Yamin; Zhou, Xihong; Zhou, Wen; Xia, Chunfang; Zhang, Ruzhe; Zhang, Zhengjie; Hu, Aiyang; Peng, Siyin; Li, Jing